Annual influenza vaccination: Offering protection beyond infection

Southern Medical Journal

Volumn 105, Issue 7, 2012, Pages 379-386

  Rogers, Kelly C ^a   Wallace, Juliet P ^a   Foster, Stephan L ^a   Finks, Shannon W ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

cardiovascular disease; cerebrovascular disease; influenza vaccine; prevention

Indexed keywords

INFLUENZA VACCINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; INCIDENCE; INFLUENZA VACCINATION; MONOCYTE; NONHUMAN; PATIENT EDUCATION; PERCUTANEOUS CORONARY INTERVENTION; RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEASONAL INFLUENZA;

CARDIOVASCULAR DISEASES; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; ISCHEMIC ATTACK, TRANSIENT; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY TRACT DISEASES; STROKE; SURVIVAL ANALYSIS;

EID: 84863766828     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31824e8db6     Document Type: Review

References (41)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statisticsV2011 update: A report from the American Heart Association. Circulation 2011;123:e18Ye209.
2. US Department of Health and Human Services. Healthy People 2020: Immunization and infectious diseases. http://healthypeople.gov/2020/ topicsobjectives2020/objectiveslist.aspx?topicId=23. Accessed June 13, 2011.
3. Health, United States, 2010: With Special Feature on Death and Dying. Hyattsville, MD: US Public Health Service; 2011.
4. Madjid M, Alfred A, Sahai A, et al. Factors contributing to suboptimal vaccination against influenza: Results of a nationwide telephone survey of persons with cardiovascular disease. Tex Heart Inst J 2009;36:546-552.
5. Public HealthWeekly Reports for November 11, 1932. Public Health Rep 1932;47:2159-2189.
6. De Diego C, Vila-Corcoles A, Ochoa O, et al. Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease. Eur Heart J 2009;30:209-216.
7. Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsyconfirmed coronary heart disease death: Results from 8 years of autopsies in 34,892 subjects. Eur Heart J 2007;28:1205-1210.
8. Madjid M, Naghavi M, Litovsky S, et al. Influenza and cardiovascular disease: A new opportunity for prevention and the need for further studies. Circulation 2003;108:2730-2736.
9. Naghavi M, Wyde P, Litovsky S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003;107:762-768.
10. Bouwman JJ,Visseren FL, BoschMC, et al. Procoagulant and inflammatory response of virus-infected monocytes. Eur J Clin Invest 2002;32:759-766.
11. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review. Lancet Infect Dis 2009;9:601-610.
12. Van Lenten BJ, Wagner AC, Nayak DP, et al. High-density lipoproteinloses its anti-inflammatory properties during acute influenza A infection. Circulation 2001;103:2283-2288.
13. Van Lenten BJ, Wagner AC, Anantharamaiah GM, et al. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation 2002;106:1127-1132.
14. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351: 2611-2618.
15. Gurfinkel EP, De La Fuente RL, Mendiz O, et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: The FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002;105:2143-2147.
16. Gurfinkel EP, Leon De La Fuente R, Mendiz O, et al. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. Eur Heart J 2004;25:25-31.
17. Gurfinkel EP, De La Fuente RL. Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. Tex Heart Inst J 2004;31:28-32.
18. Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008;29:1350-1358.
19. Phrommintikul A, Kuanprasert S, Wongcharoen W, et al. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 2011;32:1730-1735.
20. Gwini SM, Coupland CAC, Siriwardena AN. The effect of influenza vaccination on risk of acute myocardial infarction: Self-controlled caseseries study. Vaccine 2011;29:1145-1149.
21. Siriwardena AN, Gwini SM, Coupland CA. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. Can Med Assoc J 2010;182:1617-1623.
22. Mansur Ade P, Favarato D, Ramires JA. Vaccination against the influenza virus and mortality due to cardiovascular diseases in the city of Sao Paulo. Arq Bras Cardiol 2009;93:395-399, 87-91.
23. Wang CS, Wang ST, Lai CT, et al. Impact of influenza vaccination on major cause-specific mortality. Vaccine 2007;25:1196-1203.
24. Heffelfinger JD, Heckbert SR, Psaty BM, et al. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin 2006;2:161-166.
25. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-1332.
26. Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000;152:674-677.
27. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039-3045.
28. Jackson LA, Yu O, Heckbert SR, et al. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Vaccine Safety Datalink Study Group. Am J Epidemiol 2002;156:634-640.
29. Lavallee P, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002; 33:513-518.
30. Grau AJ, Fischer B, Barth C, et al. Influenza vaccination is associated with a reduced risk of stroke. Stroke 2005;36:1501-1506.
31. Burney LE. Influenza immunization: Statement. Public Health Rep 1960;75:944.
32. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1-62.
33. Hak E, Buskens E, Nichol KL, et al. Do recommended high-risk adults benefit from a first influenza vaccination? Vaccine 2006;24:2799-2802.
34. Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: The PRISMA study. Arch Intern Med 2005;165:274-280.
35. Davis MM, Taubert K, Benin AL, et al. Influenza vaccination as secondary prevention for cardiovascular disease: A science advisory from the American Heart Association/American College of Cardiology. Circulation 2006;114:1549-1553.
36. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006;47:2130-2139.
37. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary revention of cardiovascular disease and stroke: 2002 update: Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002; 106:388-391.
38. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:517-584.
39. Egede LE, Zheng D. Racial/ethnic differences in influenza vaccination coverage in high-risk adults. Am J Public Health 2003;93:2074-2078.
40. Singleton JA, Wortley P, Lu PJ. Influenza vaccination of persons with cardiovascular disease in the United States. Tex Heart Inst J 2004;31:22-27.
41. Davis MM,Wortley PM, Ndiaye SM, et al. Influenza vaccine for high-risknon-elderly adults: A national survey of subspecialists. Hum Vaccin 2008; 4:229-233.